Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.28 - $0.65 $3,080 - $7,150
-11,000 Closed
0 $0
Q1 2022

May 11, 2022

SELL
$0.56 - $0.83 $56 - $83
-100 Reduced 0.9%
11,000 $7,000
Q4 2021

Feb 08, 2022

SELL
$0.67 - $1.32 $1,636 - $3,224
-2,443 Reduced 18.04%
11,100 $8,000
Q3 2021

Nov 02, 2021

BUY
$1.02 - $1.83 $2,491 - $4,470
2,443 Added 22.01%
13,543 $18,000
Q1 2021

May 14, 2021

BUY
$0.66 - $1.4 $7,326 - $15,539
11,100 New
11,100 $11,000
Q4 2017

Feb 14, 2018

SELL
$2.24 - $4.13 $24,640 - $45,430
-11,000 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$3.35 - $3.96 $36,850 - $43,560
11,000
11,000 $39,000

Others Institutions Holding CFMS

About Conformis Inc


  • Ticker CFMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 187,856,992
  • Description
  • Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruc...
More about CFMS
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.